Photo: AP

Although he was overwhelmingly approved by the Senate, the new chief of the Food and Drug Administration, Dr. Robert Califf, clearly heard the message from the handful of senators who wanted to block his confirmation based on his association with an agency that they say has been complicit in America’s opioid epidemic.

In remarks Tuesday, Califf promised to work hard to make painkillers less addictive and to put warning labels on drugs. Recently, some opioid medications have been designed in ways to make them harder to snort or inject.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?

Jack Craver

Dig Deeper



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.